A leading obesity doctor has said a new trial of weight loss drugs Mounjaro and Wegovy may lead advertisers to reconsider their prices.

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Two blockbuster weight-loss drugs just went head-to-head — and the results are stunning. In a major new trial, Mounjaro ...

The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ...

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Stock markets rally as US and China agree to slash tariffs for at least 90 days. Also: Kurdish PKK militants end armed struggle against Turkey and Mounjaro and Wegovy go head to head in weight loss ...